EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Analysis of the Polymorphisms and Expression Levels of the BCL2, BAX and c-MYC Genes in Patients with Ovarian Cancer

Piotr Józef Olbromski, Anna Bogacz iD, Marta Bukowska, Adam Kamiński, Rafał Moszyński iD, Piotr Pawlik, Anna Szeliga, Katarzyna Kotrych, Bogusław Czerny

International Journal of Molecular Sciences · 2023

DOI: 10.3390/ijms242216309 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2023. Verfasst von Piotr Józef Olbromski und 8 weiteren Autor:innen. Beteiligte Einrichtung: Clinic of Operational Gynecology, Poznan University of Medical Sciences, Polna 33, 60-535 Poznan, Poland. Hauptthemen laut MEDLINE: Proto-Oncogene Proteins c-bcl-2, Ovarian Neoplasms. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 53 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Poznan University of Medical Sciences, Pomeranian Medical University in Szczecin.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Ovarian cancer (OC) is one of the biggest problems in gynecological oncology and is one of the most lethal cancers in women worldwide. Most patients with OC are diagnosed at an advanced stage; therefore, there is an urgent need to find new biomarkers for this disease. Gene expression profiling is proving to be a very effective tool for exploring new molecular markers for OC patients, although the relationship between such markers and patient survival and clinical outcomes is still elusive. Moreover, polymorphisms in genes encoding both apoptosis-associated proteins and oncoproteins may serve as key markers of cancer susceptibility. The aim of our study was to analyze the polymorphisms and expressions of the BCL2, BAX and c-MYC genes in a group of 198 women, including 98 with OC. The polymorphisms and mRNA expressions of the BCL2, BAX and c-MYC genes were analyzed using real-time PCR. The analysis of the BAX (rs4645878; G>A) and c-MYC (rs4645943; C>T) polymorphisms showed no association with ovarian cancer risk. The BCL2 polymorphism (rs2279115; C>A) showed a significant difference in the frequency of genotypes between the studied groups (CC: 23.47% vs. 16.00%, AA: 25.51% vs. 37.00%; p = 0.046; OR = 1.61). Furthermore, the expression levels of the BCL2 and c-MYC genes showed a decrease at the transcript level for OC patients compared to the control group (BCL2: 17.46% ± 3.26 vs. 100% ± 8.32; p < 0.05; c-MYC: 37.56% ± 8.16 vs. 100% ± 9.12; p < 0.05). No significant changes in the mRNA level were observed for the BAX gene (104.36% ± 9.26 vs. 100% ± 9.44; p > 0.05). A similar relationship was demonstrated in the case of the protein expressions of the studied genes. These findings suggest that the CC genotype and C allele of the BCL2 polymorphism could be genetic risk factors for OC development. A gene expression analysis indicated that BCL2 and c-MYC are associated with OC risk.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Proto-Oncogene Proteins c-bcl-2Ovarian NeoplasmsHumansFemalebcl-2-Associated X ProteinGenes, mycPolymorphism, Single NucleotideGenotypeApoptosis Regulatory ProteinsRNA, Messenger

Stichwörter der Autor:innen

biomarkersgene expressionindividualized therapyovarian cancerprotein expressionsingle-nucleotide polymorphism

Substanzen

bcl-2-Associated X ProteinProto-Oncogene Proteins c-bcl-2Apoptosis Regulatory ProteinsRNA, MessengerBCL2 protein, human

Autor:innen und Institutionen

  • Clinic of Operational Gynecology, Poznan University of Medical Sciences, Polna 33, 60-535 Poznan, Poland.
  • Department of Personalized Medicine and Cell Therapy, Regional Blood Center, Marcelińska 44, 60-354 Poznan, Poland.
  • Department of Orthopedics and Traumatology, Independent Public Clinical Hospital No. 1, Pomeranian Medical University, UniiLubelskiej 1, 71-252 Szczecin, Poland.
  • Department of Gynecology, Obstetrics and Gynecological Oncology, Poznan University of Medical Sciences, Polna 33, 60-535 Poznan, Poland.
  • Department of Gynecological Endocrinology, Poznan University of Medical Sciences, Polna 33, 60-535 Poznan, Poland.
  • Department of General and Dental Radiology, Pomeranian Medical University in Szczecin, al. Powstańców Wielkopolskch 72, 70-111 Szczecin, Poland.

ORCID-Profile: Anna Bogacz, Rafał Moszyński

Förderung

  • Poznan University of Medical Sciences
  • Pomeranian Medical University in Szczecin

Zitieren

APA

Olbromski, P. J., Bogacz, A., Bukowska, M., Kamiński, A., Moszyński, R., Pawlik, P., Szeliga, A., Kotrych, K., & Czerny, B. (2023). Analysis of the Polymorphisms and Expression Levels of the BCL2, BAX and c-MYC Genes in Patients with Ovarian Cancer. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms242216309

Vancouver

Olbromski PJ, Bogacz A, Bukowska M, Kamiński A, Moszyński R, Pawlik P, et al. Analysis of the Polymorphisms and Expression Levels of the BCL2, BAX and c-MYC Genes in Patients with Ovarian Cancer. International Journal of Molecular Sciences. 2023. doi:10.3390/ijms242216309

BibTeX
@article{Olbromski2023,
  author = {Olbromski, Piotr Józef and Bogacz, Anna and Bukowska, Marta and Kamiński, Adam and Moszyński, Rafał and Pawlik, Piotr and Szeliga, Anna and Kotrych, Katarzyna and Czerny, Bogusław},
  title = {Analysis of the Polymorphisms and Expression Levels of the BCL2, BAX and c-MYC Genes in Patients with Ovarian Cancer},
  journal = {International Journal of Molecular Sciences},
  year = {2023},
  doi = {10.3390/ijms242216309}
}
Kostenlos starten →